Search clinical trials for: TAK-079

Total 1521 results

Takeda

Completed

Safety and Efficacy of Ramelteon in Healthy Subjects

Sleep Disorder

United States
Takeda

Completed

Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers

Circadian Dysregulation

United States
Northwestern University
National Institute on Drug Abuse (NIDA); Emory University; Hunter College of...

Completed

Keep It Up! 2.0: A Comparison of Two Online HIV Intervention Programs for Young Men Who Have Sex With Men (KIU!)

HIV | Chlamydia | Gonorrhea

United States
Europainclinics z.ú.
Brno University Hospital; Pavol Jozef Safarik University; Slovak Academy of Sciences

Unknown

EuroPainClinicsStudy XI (Cryo vs RF MB Z Joints) (EPCS XI)

Back Pain

Slovakia
University of Minnesota
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Effect of Nutrition Labeling on Fast Food Choices

Healthy

United States
The University of Hong Kong
Health and Medical Research Fund

Recruiting

Quit Smoking: Optimizing Health Promotion Strategy

Smoking Cessation

Hong Kong
University of California, Los Angeles
Robert Wood Johnson Foundation; The John A. Hartford Foundation; California HealthCare... and other collaborators

Completed

Improving Depression Care for Elders: Coordinating Center (IMPACT)

Major Depression | Dysthymic Disorder | Both Major Depression and Dysthymic Disorder
Kuopio University Hospital

Not yet recruiting

Transcranial Alternating Current Stimulation on Patients With Delirium and Critical Illness (DeliTACS) (DeliTACS)

Delirium
Direction Centrale du Service de Santé des Armées

Recruiting

Prevention of Injury in Military Settings Through the Use of Body Awareness. (POSITION)

Traumatic Injury

France
University of Toronto
Ontario Research Fund

Unknown

Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye

Central Retinal Vein Occlusion | Branch Retinal Vein Occlusion | Central Retinal Artery Occlusion | Branch Retinal Artery Occlusion

Canada
Kwang Dong Pharmaceutical co., ltd.

Recruiting

A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)

Hypoactive Sexual Desire Disorder

Korea, Republic of
Hong Kong Sanatorium & Hospital
Chinese University of Hong Kong

Terminated

Pilot Study on Traditional Chinese Medicine and Food Allergy (TCMFA)

Allergy to Fish | Allergy to Shrimp | Allergy to Crab

Hong Kong
Shire

Completed

A Study of Lanadelumab to Prevent Hereditary Angioedema (HAE) Attacks in Children (SPRING)

Hereditary Angioedema

United States, Canada, Germany, Hungary, Spain
Henan Cancer Hospital

Not yet recruiting

Application of Douyin in Patients With Bone and Soft Tissue Malignant Tumors During Perichemotherapy

Chemotherapy | Malignant Tumor
Takeda

Recruiting

An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid Tumors

Solid Tumors

Hungary
Takeda

Recruiting

Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet

Celiac Disease

United States, Australia, Canada, New Zealand
Takeda
Nimbus Lakshmi, Inc.

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis

Psoriatic Arthritis

United States, Czechia, Germany, Poland
Takeda

Completed

Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"

Reflux Esophagitis

Japan
Takeda

Terminated

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder

Bipolar Disorder

United States, Argentina, Chile, Colombia, Mexico
Takeda

Terminated

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Bipolar Disorder

United States, Ukraine, United Kingdom, Germany, Bulgaria, Romania, Serbia, Russian Federation, Czech Republic, Poland
Aarhus University Hospital
Odense University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital and other collaborators

Recruiting

DANISH-CRT - Does Electric Targeted LV Lead Positioning Improve Outcome in Patients With Heart Failure and Prolonged QRS

Heart Failure | Branch Block, Bundle

Denmark
Millennium Pharmaceuticals, Inc.

Withdrawn

Study of TAK-733 in Combination With Alisertib in Adult Patients With Advanced Nonhematologic Malignancies

Advanced Nonhematologic Malignancies

United States
Millennium Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Mass Balance, Pharmacokinetics (PK), Metabolism and Excretion of TAK-954 Containing Microtracer ([14C]-TAK-954) in Healthy Male Participants

Healthy Volunteers

Netherlands
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Prognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian Cancer (Meta-Four)

Metastatic Ovarian Cancer

France
Takeda

Terminated

Fasiglifam 25 mg BID vs 50 mg QD

Type 2 Diabetes Mellitus

United States, Poland, Ukraine, Taiwan, Bulgaria, Romania, Slovakia
Takeda

Completed

Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease | COPD

United States
Takeda

Completed

Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.

Chronic Insomnia

United States
Takeda

Terminated

Efficacy of Ramelteon in Adults With Chronic Insomnia

Chronic Insomnia

United States
Takeda

Completed

Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase Syndrome

Sleep Disorders, Circadian Rhythm

United States
Takeda

Completed

Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia

Chronic Insomnia

United States, Canada
Takeda

Completed

Efficacy of Ramelteon on Transient Insomnia in Healthy Adults

Transient Insomnia

United States
Takeda

Completed

Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia

Sleep Initiation and Maintenance Disorders
Chinese University of Hong Kong

Not yet recruiting

Shuiniujiao Dihuang Decoction With Variation for the Treatment of Psoriasis

Psoriasis Vulgaris
Chinese University of Hong Kong

Recruiting

An Innovative Chinese Herbal Formula for the Treatment of Gout

Gout

Hong Kong
The University of Hong Kong

Unknown

Effectiveness of Multi-target FIT-DNA Analysis as a Colorectal Cancer Screening Test

Colorectal Cancer | Adenoma Colon
National Cancer Center, Korea
Jeil Pharmaceutical Co., Ltd.

Unknown

A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Advanced Non-Small Cell Lung Cancer

Korea, Republic of
National Cancer Institute (NCI)

Completed

Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery

Refractory Pancreatic Neuroendocrine Carcinoma | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2

United States
Takeda

Completed

Phase III Study of Intramuscular TAK-816 in Healthy Infants

Healthy Volunteers | Haemophilus Influenzae Type b, Prevention

Japan
Takeda

Completed

A Phase 1/2 Study of a Intramuscular Injection of TAK-850 in Healthy Adult Subjects

Influenza

Japan
Takeda

Completed

A Randomized, Double-Blind, Multicenter Study to Evaluate the Acid-inhibitory and Dose-response Efficacy of TAK-438 (20 mg, 40 mg) in Patients With Proton Pump Inhibitor (PPI) - Resistant Erosive Esophagitis

Erosive Esophagitis

Japan
Takeda

Withdrawn

A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants

Influenza Prevention

Japan
Presage Biosciences
Takeda

Completed

PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC

Head and Neck Squamous Cell Carcinoma

United States
Rhythm Pharmaceuticals, Inc.

Completed

Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Participants With Moderate to Severe Obesity

Bardet Biedl Syndrome (BBS) | Alström Syndrome (AS)

United States, United Kingdom, France, Canada, Puerto Rico, Spain
Takeda

Active, not recruiting

A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet

Celiac Disease

United States, Belgium, Poland, Italy, Canada, United Kingdom, France, Spain
Takeda

Completed

TAK-329 Glucose Clamp Study

Type 1 Diabetes Mellitus

United States
Takeda

Completed

Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Participants

Healthy Volunteers

United States
Shire
Takeda Development Center Americas, Inc.

Withdrawn

Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia

COVID-19 Pneumonia
Chinese University of Hong Kong

Recruiting

Chinese Medicine for Patients With Psoriasis

Psoriasis

Hong Kong
The University of Hong Kong

Unknown

Tobacco Control-Related Policy Survey

Survey on Tobacco Control

Hong Kong
Qilu Hospital of Shandong University

Recruiting

Effects of Levosimendan on Cardiac Function After TAVR in Patients With Heart Failure

Heart Failure | Aortic Stenosis, Severe

China

Search clinical trials for: TAK-079

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations